Maeda H, Yao H, Go H, Huntington K, De Paepe M, Dennery P
Respir Res. 2022; 23(1):340.
PMID: 36496404
PMC: 9741793.
DOI: 10.1186/s12931-022-02263-8.
Volovat S, Augustin I, Zob D, Boboc D, Amurariti F, Volovat C
Cancers (Basel). 2022; 14(19).
PMID: 36230757
PMC: 9562853.
DOI: 10.3390/cancers14194834.
Diaz-Pina G, Rubio K, Ordonez-Razo R, Barreto G, Montes E, Becerril C
Int J Mol Sci. 2022; 23(16).
PMID: 36012303
PMC: 9409484.
DOI: 10.3390/ijms23169028.
Gao J, Fan Y, Gao S, Zhang W
Reprod Sci. 2022; 30(2):464-472.
PMID: 35764858
DOI: 10.1007/s43032-022-01019-5.
Liu C, Chen Z, Fang M, Qiao Y
Transl Cancer Res. 2022; 8(5):1763-1771.
PMID: 35116927
PMC: 8799222.
DOI: 10.21037/tcr.2019.08.30.
Epigenetic interplay between methylation and miRNA in bladder cancer: focus on isoform expression.
Shivakumar M, Han S, Lee Y, Kim D
BMC Genomics. 2021; 22(Suppl 3):754.
PMID: 34674656
PMC: 8529714.
DOI: 10.1186/s12864-021-08052-9.
Knockdown of miR-183 Enhances the Cisplatin-Induced Apoptosis in Esophageal Cancer Through Increase of FOXO1 Expression.
Chen H, Zheng B, Xue S, Chen C
Onco Targets Ther. 2020; 13:8463-8474.
PMID: 32943877
PMC: 7468590.
DOI: 10.2147/OTT.S258680.
miR-205/RunX2 axis negatively regulates CD44/CD24 breast cancer stem cell activity.
Zhang L, Liu L, Xu X, He X, Wang G, Fan C
Am J Cancer Res. 2020; 10(6):1871-1887.
PMID: 32642297
PMC: 7339278.
Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.
Wu D, Zhu X, Wen X, Zhang Y, Ma J, Yao D
Mol Genet Genomic Med. 2019; 8(1):e1067.
PMID: 31833222
PMC: 6978398.
DOI: 10.1002/mgg3.1067.
MicroRNA‑206 exerts anti‑oncogenic functions in esophageal squamous cell carcinoma by suppressing the c‑Met/AKT/mTOR pathway.
Zhang J, Fa X, Zhang Q
Mol Med Rep. 2018; 19(3):1491-1500.
PMID: 30569129
PMC: 6390054.
DOI: 10.3892/mmr.2018.9775.
Targeting PDK4 inhibits breast cancer metabolism.
Guda M, Asuthkar S, Labak C, Tsung A, Alexandrov I, Mackenzie M
Am J Cancer Res. 2018; 8(9):1725-1738.
PMID: 30323966
PMC: 6176187.
Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T, Gao X, Han L, Yu J, Li H
World J Surg Oncol. 2018; 16(1):114.
PMID: 29921304
PMC: 6009060.
DOI: 10.1186/s12957-018-1409-3.
MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.
Kan Q, Su Y, Yang H
Oncol Lett. 2018; 14(6):7622-7628.
PMID: 29344210
PMC: 5755184.
DOI: 10.3892/ol.2017.7126.
miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
Mayoral-Varo V, Calcabrini A, Sanchez-Bailon M, Martin-Perez J
PLoS One. 2017; 12(11):e0188637.
PMID: 29182685
PMC: 5705145.
DOI: 10.1371/journal.pone.0188637.
Targeting MicroRNA in Cancer Using Plant-Based Proanthocyanidins.
Bansode R, Khatiwada J, Losso J, Williams L
Diseases. 2017; 4(2).
PMID: 28933401
PMC: 5456277.
DOI: 10.3390/diseases4020021.
MicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients.
Shoji H, Isomoto H, Yoshida A, Ikeda H, Minami H, Kanda T
Exp Ther Med. 2017; 14(2):898-904.
PMID: 28810541
PMC: 5526122.
DOI: 10.3892/etm.2017.4598.
Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Shivakumar M, Lee Y, Bang L, Garg T, Sohn K, Kim D
BMC Med Genomics. 2017; 10(Suppl 1):30.
PMID: 28589857
PMC: 5461531.
DOI: 10.1186/s12920-017-0269-y.
miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.
Li Y, Wu D, Wang P, Li X, Shi G
Dis Markers. 2017; 2017:8317913.
PMID: 28487599
PMC: 5402242.
DOI: 10.1155/2017/8317913.
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.
Kim J, Park W, Jeong K, Kang S, Kwon S, Kim S
Int J Genomics. 2017; 2017:5789769.
PMID: 28352639
PMC: 5352891.
DOI: 10.1155/2017/5789769.
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Lin Z, Chen G, Zhang Y, He H, Liang Y, Ye J
Mol Cancer. 2017; 16(1):48.
PMID: 28241827
PMC: 5327510.
DOI: 10.1186/s12943-017-0615-x.